{
  "url": "https://www.law.cornell.edu/regulations/new-york/14-NYCRR-822.5",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 14 ยง 822.5 - Definitions",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 14 ยง 822.5 - Definitions\n\nState Regulations\n\nAs used in this Part, unless otherwise indicated, the\nfollowing terms shall be applicable all programs providing outpatient\nservices: (a) \"Accrediting Body\" means\nan entity approved by the federal Substance Abuse Mental Health Services\n\nAdministration (SAMHSA) to accredit all programs pursuant to 42 CFR Part\n8.1\nthrough 8.6 using opioid full agonist treatment medications. (b) \"Active treatment\" is the period from\npre-admission through discharge. (c) \"Admission assessment\" is a service\nbetween a prospective patient and clinical staff for the purpose of determining\na preliminary diagnosis, appropriateness for service, person-centered initial\nplan of treatment, including type(s) of services and frequency of\nservices. (d) \"Ancillary\nwithdrawal\" is a service whereby patients in mild to moderate or persistent\nwithdrawal receive symptom relief and/or addiction medications after an\nassessment of the level of withdrawal determined using a standardized\nassessment instrument. Providers must receive Office approved designation to\nprovide this service. (e) \"Approved\nmedications\" means any medication approved by state or federal authorities for\nthe treatment of substance use disorder. (f) \"Brief intervention\" is a service between\na prospective patient and clinical staff when screening results indicate at\nrisk behavior. The brief intervention educates patients about their substance\nuse, alerts them to possible consequences, and is intended to encourage\nhealthier choices. (g) \"Brief\ntreatment\" is a service between an active patient and clinical staff and must\ninclude a target behavior or health need and an evidence-based or clinical\npractice upon which the treatment is based. Brief treatment may be used\nthroughout the course of treatment to meet specific goals, motivate patients or\nsupport medicated supported recovery. (h) \"Central registry system\" means the\ncentral registry established and maintained by the Office pursuant to section\n19.16\nof\nthe Mental Hygiene Law. (i) \"Collateral person\" is a member of a patient's family or household, significant\nothers, or persons who are directly affected by regular interaction with the\npatient, or who have the capability to affect both the patient's substance use\ndisorder and recovery. (j) \"Collateral visit\" is a service between a clinical staff member and a\ncollateral person for the purpose of providing an intervention in the service\nof the primary patient's progress in treatment. (k) \"Complex care coordination\" is an\nancillary service provided to a patient when a critical event occurs, or the\nindividual's condition requires significant coordination with other service\nproviders. Complex care coordination is distinguished from routine case\ncoordination activities. (l) \"Continuing care treatment\" is a treatment protocol that offers clinical\nsupport for the ongoing substance use management needs of patients. Patients\nhave either completed the goals of active treatment and are discharged with\nreferral to continuing care or opt for continuing care any time after\ndischarge. (m) \"Group counseling\"\nis a service between one or more clinical staff and multiple patients at the\nsame time, to be delivered consistent with patient treatment/recovery plans, their development or emergent issues. Group counseling sessions must be\nstructured in size and duration to maximize therapeutic benefit for each\nparticipant. Program policies must include a process for determining group\nsize, group purpose, monitoring patient experience, and assessing group\nefficacy. (n) \"Individual\ncounseling\" is a service between a clinical staff member and a patient focused\non the needs and goals of the patient to be delivered consistent with the\ntreatment/recovery plan, its development or emergent issues. (o) \"Initial services or pre-admission\nservices\" are services prior to admission as the first step in developing a\ntreatment/recovery plan, focusing on issues that need to be addressed to ensure\nsuccessful engagement and admission into treatment and any other urgent or\nemergent issues. Initial/pre-admission services address priority goals based on\npresenting problem(s) identified during the patient's assessment and provide\nfocus for the critical period of treatment engagement. Services which may be\ndelivered preadmission will be identified by the Office. (p) \"Intensive outpatient services\" (IOS) is\nan outpatient treatment service provided by a team of clinical staff for\npatients who require a time-limited, multi-faceted array of services, structure, and support to achieve and sustain recovery. Programs that offer\nintensive outpatient treatment must make available individual and group\ncounseling, family counseling when appropriate, skills to mitigate\nreoccurrence, and coping skills training, including as appropriate, Dialectical\nand Behavioral Therapy (DBT), Motivational Enhancement Therapy (MET), Cognitive\n\nBehavioral Therapy (CBT) and increased connections to recovery supports and\nother evidence based practices as proven effective in meeting patient\nneeds. (q) \"Medication\nadministration and observation\" is face-to-face administration or dispensing of\na medication by medical staff, to be delivered in conjunction with observation\nof the patient prior to the administration and after, as appropriate to the\nmedication and patient's condition. (r) \"Medication for addiction treatment\"\n(MAT) means treatment of substance use disorder i.e., substance use disorder\nand concomitant conditions with medications requiring a prescription or order\nfrom an authorized prescribing professional with counseling and behavioral\ntherapies, as clinically appropriate. (s) \"Medication management\" is a service with\na prescribing professional for one of the following purposes: (1)\nevaluation, monitoring, observation or\ndosage change to a patient's medication; (2)\na comprehensive medication review of a\nnew patient or any patient who requires a more extensive review; or\n(3)\nthe induction of a patient to a new\nmedication requiring a period of patient observation. (t) \"Naloxone emergency overdose prevention\nkit\" means a kit as prescribed pursuant to state law and is used to reverse an\nopioid overdose. (u) \"Opioid medical\nmaintenance\" is a designated Office-based opioid treatment (\"OBOT\") program\nlimited to patients who meet specific criteria as described in this\n\nPart. (v) \"Opioid taper\" means a\nmedical treatment protocol that, after a period of stabilization, utilizes\napproved medications in gradually decreasing doses to the point of 0 milligrams\n(no dose) followed by continuing care treatment as described in this Part, or\ndischarge. (w) \"Patient\" for\npurposes of this Part is an individual including a significant other who meets\nwith clinical and/or peer staff for the purpose of engagement, assessment or\ntreatment. \"Active patient\" means a patient who is admitted to a program and\nhas an active treatment/recovery plan. (x) \"Peer support service\" is provided by a\npeer advocate as defined in Part 800 of this Title. Peer support services are\nservices for the purpose of outreach for engaging an individual to consider\nentering treatment, reinforcing current patients' engagement in treatment, and\nconnecting patients to community-based recovery supports consistent with\ntreatment/recovery and discharge plans. (y) \"Person centered care\"is a collaborative\ncare approach to individualized treatment resulting in the development of\ntreatment/recovery plan goals and service provision that is respectful of the\npatient's needs and choices. It is guided by patients and produced in\npartnership with care providers for treatment and recovery. Person and family\ncentered care planning is strength-based and focuses on individual capacities, preferences and goals. It supports patient preferences and a recovery\norientation and is developed within the professional responsibilities of\nproviders and care teams. (z) \"Progress note\" is documentation of each service delivered and serves as the\ntreatment/recovery plan as it evolves to support person centered goals and\nongoing service and care planning. Progress notes identify patient's clinical\nstatus, type of services, and may also include updates to goals, methods of\ntreatment and types of services provided and includes challenges and\nachievements identified. (aa)\n\"Screening\" is a pre-admission service with a clinical staff member for the\npurpose of identifying patients who have problems with substance use. Screening\nresults must be shared by the clinical staff with the patient. (ab)\n\"Specialized opioid services\"are those\nnot defined in this Part and are generally research-oriented in nature. Such\nspecialized services shall be reviewed and approved by the Office prior to\nimplementation and operation in accordance with Office policy, procedures, and\nrequirements. (ac)\n\"Substance use\ndisorder outpatient rehabilitation services\"(outpatient rehabilitation\nservices) are services offered by programs which have been certified to provide\noutpatient rehabilitation services; such services are designed to assist\nindividuals with more chronic conditions as further defined in this Part who\nare typically scheduled to attend the outpatient rehabilitation program three\nto five days per week for at least two hours per day. (ad)\n\"Substance use disorder outpatient\nprogram\"is an Office certified program which provides outpatient services that\nassist individuals with a substance use disorder and their family members\nand/or significant others and may also provide outpatient rehabilitation\nservices and/or intensive outpatient services (IOS); and sites where addiction\nmedications are administered to treat opioid use disorder, as well as other\nSUDs following one or more medical treatment protocols as defined in this Part. This term encompasses medical and comprehensive support services including\ncounseling, educational and vocational rehabilitation. The term also includes\nthe Narcotic Treatment Program (NTP) as defined by the federal Drug Enforcement\n\nAgency (DEA) in\n21 CFR\nSection 1301. An NTP or Opioid Treatment Program (OTP)\nrequires federal and state approval. (ae)\n\"Transfer\"is an intra-program function\n(i.e., between outpatient and outpatient rehabilitation within the same\nprovider or between different Program Reporting Units (PRUs) of the same\nprovider); and may also be an inter-program function (i.e., between two\ndifferent providers). (af)\n\"Treatment/recovery plan\" is the plan developed by clinical staff with the\npatient and based on the admission assessment and initial services and includes\ngoals, type and frequency of services and methods. Treatment/recovery plans\nshall be regularly updated using progress notes. (ag)\n\"Visit\" means one or more services\nprovided to a patient and/or collateral person on a single\nday. Notes\nN.Y. Comp. Codes\nR. & Regs. Tit. 14\nยง\n822.5\n\nAdopted\n\nNew\n\nYork State Register December 9, 2015/Volume XXXVII, Issue 49, eff. 11/20/2015\n\nAmended\n\nNew\n\nYork State Register December 6, 2017/Volume XXXIX, Issue 49, eff. 12/6/2017\n\nAdopted\n\nNew\n\nYork State Register March 27, 2019/Volume XLI, Issue 13, eff. 3/27/2019\n\nAmended\n\nNew\n\nYork State Register January 27, 2021/Volume XLIII, Issue 04, eff. 1/27/2021\n\nAmended\n\nNew\n\nYork State Register September 14, 2022/Volume XLIV, Issue 37, eff. 10/1/2022\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 28196
}